Business
Rapid Micro Biosystems Reports First Quarter 2025 Financial Results
Reports first quarter 2025 total revenue of $7.2 million, representing 28% growth compared to the first quarter of 2024. Reports record quarterly service revenue led by strong validation activity. Reports first quarter gross margin of 6%, representing a 33-percentage point improvement compared to the first quarter of 2024.Announced a global Distribution and Collaboration Agreement with the Life Science business of Merck KGaA, Darmstadt, Germany, which operates in the U.S. as MilliporeSigma (“Mil
About this update from Rapid Micro Biosystems, Inc.
[{"type":"image","alt":"Rapid Micro Biosystems, Inc.","displaySize":"","headline":null,"caption":"Rapid Micro Biosystems, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":155,"url":"https://media.zenfs.com/en/globenewswire.com/f730ec7c95983a2372a93ee6e7f390c0"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/t0NXhkXriNft2AMfxGKlHw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIxNztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/f730ec7c95983a2372a93ee6e7f390c0","width":300,"height":155}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Reports first quarter 2025 total revenue of $7.2 million, representing 28% growth compared to the first quarter of 2024.","length":120,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Reports record quarterly service revenue led by strong validation activity.","length":75,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":75,"olType":false}]}],"tagName":"ul","bulletedList":true,"length":195,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"Reports first quarter gross margin of 6%, representing a 33-percentage point improvement compared to the first quarter of 2024.","length":127,"tagName":"p"}]},{"val":[{"type":"text","content":"Announced a global Distribution and Collaboration Agreement with the Life Science business of Merck KGaA, Darmstadt, Germany, which operates in the U.S. as MilliporeSigma (“MilliporeSigma”). ","length":190,"tagName":"p"}]},{"val":[{"type":"text","content":"Reaffirms full-year 2025 total revenue guidance of at least $32.0 million.","length":74,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":391,"olType":false},{"type":"text","content":"LEXINGTON, Mass., May 09, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced its financial results for the first quarter ended March 31, 2025.","length":382,"tagName":"p"},{"type":"text","content":""We delivered strong revenue growth of 28% in the first quarter, which included record quarterly service revenue,” said Robert Spignesi, President and CEO. "We also continued to make good progr...